Kopp, Sebastian-Paul;
Medvedev, Vadim;
Tangermann-Gerk, Katja;
Wöltinger, Natalie;
Rothfelder, Richard;
Graßl, Fabian;
Heinrich, Markus R;
... Schmidt, Michael; + view all
(2023)
Electrophotographic 3D printing of pharmaceutical films.
Additive Manufacturing
, 73
, Article 103707. 10.1016/j.addma.2023.103707.
Preview |
Text
1-s2.0-S2214860423003202-main.pdf - Published Version Download (15MB) | Preview |
Abstract
The usage of three-dimensional (3D) printing in pharmaceutical applications offers significant advantages compared to conventional manufacturing approaches such as tableting or encapsulation. Laser sintering (LS), also referred to as powder bed fusion – laser beam (PBF-LB), formerly also known as selective laser sintering (SLS), offers the production of pharmaceuticals directly from a powder mixture with high geometrical flexibility and adjustable release profiles. However, due to limitations of conventional powder application methods for PBF-LB, neither the material composition nor the material distribution can be tailored within a printed layer. To overcome these restrictions, electrophotographic powder application (EPA), a novel method for selective powder application, was utilized in this study. EPA allows the deposited layer thickness to be reduced to values between 12 and 76 µm, depending on the used pharmaceutical powder blend. Thus, the laser energy input required for interlayer connection can be reduced, enabling the use of a CO2 laser. In this study, for the first time, EPA in combination with powder bed fusion – laser beam of polymers (EPA-PBF-LB/P) was utilized to successfully deposit and print three different model drugs: paracetamol, nicotinamide, and caffeine, mixed with Eudragit L 100–55, a pharmaceutical grade polymer. Through the use of EPA, thin layers of powder blends were successfully deposited in the build chamber, leading to no thermal degradation of the polymer or drugs from the use of a CO2 laser. Single- and multi-material pharmaceutical films were successfully printed via EPA-PBF-LB, utilizing EPA to selectively as well as precisely apply different powders within a single layer into the build chamber. This introduces a novel method of printing pharmaceuticals using SLS with a CO2 laser and without the use of additional colorants.
Type: | Article |
---|---|
Title: | Electrophotographic 3D printing of pharmaceutical films |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.addma.2023.103707 |
Publisher version: | https://doi.org/10.1016/j.addma.2023.103707 |
Language: | English |
Additional information: | Copyright © 2023 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Keywords: | Additive manufacturing; Electrophotography; Printed pharmaceuticals; Laser powder bed fusion; Laser sintering; Multi-material printing |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy > Pharmaceutics |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10182382 |
Archive Staff Only
![]() |
View Item |